Insulin-like Growth Factor 2 and Insulin-like Growth Factor Binding Protein 2 Expression in Hepatoblastoma
Overview
Affiliations
The expression of insulin-like growth factor 2 (IGF2) and insulin-like growth factor binding protein 2 (IGFBP2) in 11 cases of hepatoblastoma was studied by means of in situ mRNA hybridization using digoxigenin (DIG)-labeled riboprobes. The results showed that both IGF2 and IGFBP2 transcripts are present in hepatoblastoma and that their expression is inversely correlated with the degree of tumor cell differentiation. The data suggested that IGF2 and IGFBP2 gene expression could be regarded as a marker for assessment of the degree of differentiation in hepatoblastoma.
Wu P, Fish M, Hazard F, Zhu C, Vennam S, Walton H Nat Commun. 2024; 15(1):10007.
PMID: 39567523 PMC: 11579301. DOI: 10.1038/s41467-024-53802-4.
Alrashid M, Al-Serri A, Hussain R, Al-Bustan S, Al-Barrak J Biomedicines. 2023; 11(12).
PMID: 38137390 PMC: 10740888. DOI: 10.3390/biomedicines11123166.
Molecular Mechanisms of Hepatoblastoma.
Zhang Y, Solinas A, Cairo S, Evert M, Chen X, Calvisi D Semin Liver Dis. 2021; 41(1):28-41.
PMID: 33764483 PMC: 8524782. DOI: 10.1055/s-0040-1722645.
Liao J, Zeng T, Pierce N, Tran D, Singh P, Mann J Cell Rep. 2021; 34(6):108729.
PMID: 33567274 PMC: 7968144. DOI: 10.1016/j.celrep.2021.108729.
Preclinical and Clinical Epigenetic-Based Reconsideration of Beckwith-Wiedemann Syndrome.
Papulino C, Chianese U, Nicoletti M, Benedetti R, Altucci L Front Genet. 2020; 11:563718.
PMID: 33101381 PMC: 7522569. DOI: 10.3389/fgene.2020.563718.